Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats
- 1 December 2007
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 72 (11), 1345-1357
- https://doi.org/10.1038/sj.ki.5002540
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Dyslipidemia and the progression of renal disease in chronic renal failure patientsKidney International, 2005
- The association between atherosclerotic risk factors and renal function in the general populationKidney International, 2005
- Hyperlipidemia aggravates renal disease in B6.ROP Os/+ miceKidney International, 2004
- Body mass index is associated with altered renal hemodynamics in non-obese healthy subjectsKidney International, 2004
- After all those fat years: renal consequences of obesityNephrology Dialysis Transplantation, 2003
- Adipose tissue as a source of inflammatory cytokines in health and disease: Focus on end-stage renal diseaseKidney International, 2003
- Renal Injury in Apolipoprotein E–Deficient MiceLaboratory Investigation, 2002
- Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritisAmerican Journal of Kidney Diseases, 2001
- Obesity-related glomerulopathy: An emerging epidemicKidney International, 2001
- Association between Very-Low-Density Lipoprotein and Glomerular Injury in Obese Zucker RatsAmerican Journal of Nephrology, 1993